Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Decision Making: P-value Method

Decision Making: P-value Method

The process of hypothesis testing based on the P-value method includes calculating the P- value using the sample data and interpreting it.
First, a specific claim about the population parameter is proposed. The claim is based on the research question and is stated in a simple form. Further, an opposing statement to the claim is also stated. These statements can act as null and alternative hypotheses: a null hypothesis would be a neutral statement while the alternative hypothesis can have a...

Ethical Issues

Ethical Issues

Nurses are essential in patient care, upholding the ethical principles of their profession and effectively navigating ethical dilemmas. Neglecting ethical issues can lead to inadequate patient care, compromised therapeutic relationships, and moral distress among healthcare workers.
Ethical Concerns in Healthcare:

Drug Distribution: Plasma Protein Binding

Drug Distribution: Plasma Protein Binding

Drugs predominantly attach to plasma proteins, with only a small percentage remaining unbound. The unbound portion can be calculated as one minus the bound fraction. Acidic drugs form large, inactive complexes by reversibly binding to plasma albumin, which prevents them from diffusing across biological barriers. These drug-protein complexes act as reservoirs for the drugs. As the concentration of unbound drugs decreases, these complexes quickly dissociate to release the free drug, maintaining...

Inductively Coupled Plasma-Mass Spectrometry (ICP-MS): Interferences

Inductively Coupled Plasma-Mass Spectrometry (ICP-MS): Interferences

Inductively coupled plasma–mass spectrometry (ICP–MS) is a highly selective and sensitive technique for accurate elemental analysis. Though the analysis of ICP–MS mass spectra is comparatively straightforward, it is affected by spectroscopic and non-spectroscopic interferences. Spectroscopic interferences arise when the plasma contains ionic species with an m/z value the same as the analyte ion. Spectroscopic interference can be categorized as isobaric, polyatomic ions, and refractory oxide ion...

Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions

Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions

PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure (CHF).

Pharmaceutical Poisoning: Potential Scenarios

Pharmaceutical Poisoning: Potential Scenarios

Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Private equity takeovers are harming patients.

BMJ (Clinical research ed.)·2023

Same author

The false promise of state-based reform.

Modern healthcare·2019

Same author

'Pricing now appears to more accurately match medical costs'.

Modern healthcare·2019

Same author

It's not that complicated To: President Donald Trump From: HHS Secretary Tom Price Re: It's complicated.

Modern healthcare·2019

Same author

Blame Congress for the coming 'death spiral'.

Modern healthcare·2019

Same author

Give Verma a chance.

Modern healthcare·2019

Search research articles

Related Experiment Video

Updated: Jul 24, 2026

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

Dr. Price's conflicts of interest.

Merrill Goozner

Modern Healthcare

|January 16, 2019

Summary

Democratic senators criticized HHS secretary designee Dr. Tom Price for his stock trading in healthcare equities. His significant investments raised ethical concerns regarding potential conflicts of interest.

Area of Science:

Political Science
Public Health Policy
Financial Ethics

Background:

Members of the U.S. Senate, including those involved in healthcare policy, engage in stock trading.
The designation of a Health and Human Services (HHS) secretary nominee raises questions about financial disclosures and potential conflicts of interest.
Public scrutiny of political figures' financial dealings, particularly in sectors they regulate, is a key aspect of governmental accountability.

Purpose of the Study:

To examine the ethical implications of the HHS secretary designee's personal investments in healthcare stocks.
To analyze the appropriateness of political figures trading equities within their sector of oversight.
To evaluate the role of legislative oversight in addressing potential conflicts of interest in public service.

Main Methods:

More Related Videos

Involving Individuals with Developmental Language Disorder and Their Parents/Carers in Research Priority Setting

Involving Individuals with Developmental Language Disorder and Their Parents/Carers in Research Priority Setting

Published on: June 6, 2020

Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease

Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease

Published on: August 9, 2024

Related Experiment Videos

Last Updated: Jul 24, 2026

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

Involving Individuals with Developmental Language Disorder and Their Parents/Carers in Research Priority Setting

Involving Individuals with Developmental Language Disorder and Their Parents/Carers in Research Priority Setting

Published on: June 6, 2020

Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease

Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease

Published on: August 9, 2024

Review of public financial disclosure records for the HHS secretary designee.
Analysis of legislative debates and public statements concerning the nominee's stock trading activities.
Examination of ethical guidelines and regulations pertaining to financial investments by public officials.

Main Results:

The HHS secretary designee made significant investments in individual healthcare equities.
Democratic senators raised concerns about the propriety of these investments, citing potential conflicts of interest.
The scrutiny highlighted the tension between personal financial freedom and public trust in political office.

Conclusions:

The case of Dr. Tom Price underscores the importance of transparency and ethical conduct for public officials, especially in healthcare.
Robust oversight mechanisms are crucial to prevent conflicts of interest and maintain public confidence.
The trading of healthcare stocks by those in positions of power warrants continued ethical and political examination.